Sartorius Stedim Biotech and Novasep to develop novel systems for membrane chromatography

Goettingen | Germany, March 05, 2019 Sartorius Stedim Biotech (SSB), a leading supplier for the biopharmaceutical industry, and Novasep based in Pompey, France, have entered into a collaboration agreement in the area of chromatography and single-use bioprocessing. Novasep provides various products and services to the life science industry, based on specialized technologies. In particular, this... Read more

Colin McCracken Joins Fluidigm as Chief Commercial Officer

SOUTH SAN FRANCISCO, Calif., March 05, 2019 (GLOBE NEWSWIRE) — Fluidigm Corporation (NASDAQ:FLDM) today announced that Colin McCracken has joined the company as its Chief Commercial Officer. McCracken will be responsible for leading all commercial activities, driving revenue growth in new and existing markets and expanding the company’s global reach. As a member of the executive leadership team reporting to President... Read more

Open Letter to Versum Shareholders from Merck KGaA, Darmstadt, Germany

05 MAR 2019 | DARMSTADT, GERMANY Merck KGaA, Darmstadt, Germany, a leading science and technology company, today issued an open letter to the shareholders of Versum Materials, Inc. (“Versum”). On March 1, the Versum Board of Directors without any further explanation rejected Merck KGaA, Darmstadt, Germany’s superior proposal to acquire all of the outstanding common stock of... Read more

Canopy Biosciences Announces Exclusive License for Error Corrected Sequencing Technology

M ST. LOUIS, March 5, 2019 /PRNewswire/ — Canopy Biosciences™ LLC, a leading provider of gene editing and gene expression products and services, announced today that they had exclusively licensed technology for error correction in next generation sequencing (NGS) from Washington University.  This license includes both a novel method and bioinformatic tools that combine to significantly improve... Read more

MilliporeSigma Awarded Canadian CRISPR Nickase Patent for Foundational Genome-Editing Technology

04 MAR 2019 | BURLINGTON, MASSACHUSETTS, UNITED STATES OF AMERICA Patent covers paired Cas9 nickase technology to advance gene therapy and research, reduce off-target effects Marks MilliporeSigma’s 13th CRISPR patent overall Actively licensing CRISPR-related patents to interested parties Burlington, Massachusetts, March 4, 2019 – MilliporeSigma, a leader in genome editing, today announced that the Canadian Patent Office has allowed... Read more

Bruker Expands Pharma and Industrial NMR, EPR and Software Solutions

HILTON HEAD ISLAND, South Carolina, March 4, 2019: Bruker is expanding its pharma and industrial NMR, EPR and related software solutions at PANIC 2019, the ‘Practical Applications of NMR in Industry Conference’ (www.panicnmr.com). The new productivity and compliance tools include: New Compliance Tools for Regulated Markets: Adherence to compliance with GxP is mandatory in regulated environments of... Read more

Organizing images from any source to connect multi-modal data

ZEISS ZEN Connect for the materials research lab JENA/Germany, 2019-03-04. ZEISS ZEN Connect software module is now available for materials researchers at universities, multi-user facilities or industrial labs. It enables users to bring all imaging technologies together – ZEISS or otherwise – to answer their questions. Gaining unique insights and saving time ZEISS ZEN Connect... Read more

Lonza Completes Divestment of Water Care Business

March 01,2019 NEWS RELEASE PDF Basel (CH), 1 March 2019 – Lonza announced today the completion of the divestment of its former Water Care business and operations to Platinum Equity for USD 630 million. The strategic agreement between both parties was already announced on 1 November 2018. Lonza plans to re-invest parts of the proceeds of the Water... Read more

Crown Bioscience and The Jackson Laboratory Collaboration Enables Global Access to FATZO Mouse

Continued Collaboration Facilitates Global Distribution of Obesity, Metabolic Disease, and NASH Model and Priority Supply to CrownBio’s World-Class Cardiovascular, Obesity, and Metabolic Disease Platform San Diego, Calif. – March 5, 2019 – Crown Bioscience, a global drug discovery and development services company, providing translational platforms to advance oncology, inflammation, cardiovascular and metabolic disease research today announced... Read more